Mochi Health offers compounded semaglutide at $175/month with a $50 initial evaluation. The brand has a strong social media presence and the onboarding experience is clean. Clinical responsiveness was good — we received a provider response within 6 hours. Shipping averaged 6 days.
Learn More →Best Alternatives to Ro Body for GLP-1 Weight Loss
Ro's $145/month membership fee turns a competitive medication into one of the most expensive options on the market. Here's what to use instead.
Ro (formerly Roman) has built a respected telehealth brand. Their weight loss program, Ro Body, offers semaglutide prescriptions with insurance navigation support — a genuine differentiator for patients with qualifying coverage.
But for uninsured patients or those whose insurance won't cover GLP-1s (which is most people), Ro Body's cost structure is brutal. The medication itself runs $299/month, and there's a mandatory $145/month "membership fee" on top of that. A 3-month minimum commitment means you're locked in for at least $1,332 before you can cancel.
We tested five alternatives that deliver the same clinical outcome — a legitimate semaglutide or tirzepatide prescription — without the membership tax. Here's how they stacked up.
The 5 Best Ro Body Alternatives
The math tells the story: Telehealth FX costs $146/month. Ro Body costs $444/month. Both provide compounded semaglutide through board-certified physicians via telehealth. The clinical outcome is the same — the price difference is entirely due to Ro's membership layer and higher medication markup.
Beyond pricing, Telehealth FX matched or beat Ro Body on every metric we tested. Physician review was same-day (Ro averaged 2 days). Shipping took 4 days (Ro averaged 6). And crucially, there are no contracts — you can pause or cancel anytime without penalty, while Ro locks you into a 3-month minimum.
Telehealth FX also offers tirzepatide, which Ro Body does not. For patients who've plateaued on semaglutide or whose physician recommends the dual-agonist approach, that flexibility matters.
Visit Telehealth FX →Lemonaid (owned by 23andMe) offers both async and video consultations for semaglutide at $195/month. The $25 recurring consultation fee every quarter adds up, and a recent lab work requirement at the 6-month mark ($75) introduces additional cost. But the async option is convenient for busy schedules.
Learn More →Alpha Medical has been operating since 2018 with a broad telehealth menu. Their GLP-1 program runs $225/month plus a $30/month platform fee — totaling $255/month. Cheaper than Ro, but still carries a membership layer. The clinical process is thorough and their physician network is well-established.
Learn More →Done (formerly Done ADHD) expanded into weight management in 2025. They offer semaglutide at $210/month with a unique angle: integrated treatment for patients managing both ADHD and weight loss. If that's your situation, the combined approach has merit. For weight loss alone, it's mid-tier on pricing and lacks the flexibility of our top picks.
Learn More →Frequently Asked Questions
Why is Ro Body so expensive?
Ro charges a $145/month membership fee on top of $299/month medication costs, plus requires a 3-month minimum commitment. Total out-of-pocket can reach $444+/month without insurance coverage — making it one of the priciest GLP-1 options available.
Which Ro alternative has no membership fee?
Telehealth FX charges $146/month all-in with no membership fee, no contracts, and no hidden charges. Mochi Health ($175/month) and Lemonaid Health ($195/month) also avoid monthly membership structures.
Does Ro Body accept insurance?
Ro offers insurance navigation and prior authorization support, which is a genuine advantage for patients with qualifying coverage. However, the $145/month membership fee applies regardless of insurance status, and most plans still don't cover GLP-1s for weight loss.
Can I cancel Ro Body and switch providers?
Yes, though Ro requires you to complete your 3-month minimum commitment period first. Most alternative providers can onboard you within 24–48 hours with a new medical evaluation.